Share
SGLT2 inhibitors were designed to lower glucose, but clinical trials uncovered unexpected cardiovascular and renal benefits. Updated guidelines from the American Diabetes Association now recommends SGLT2 inhibitors in type 2 diabetes patients to lower glucose. The evidence is clear that SGLT2 inhibitors should be added to the drug regimen of many type 2 diabetes patients,...
Share
Two years after Medicare began covering the use of continuous glucose monitors by seniors, the advantages are becoming clear. However, patient education on the proper use of these systems is vital to their success. Some two years after Medicare began covering the use of continuous glucose monitors (CGM), seniors are increasingly reporting benefits, and a...
Share
Patients and providers generate incredible amounts of data every day. Can it be put to better use in individualizing care? Endocrine News looks out how using information that already exists could dramatically improve patient care as well as scientific research. Love ’em or hate ’em, there could be gold in those electronic health records. The University...
Share
A drug used to treat type 2 diabetes could offer a simple and cheap solution to reduce dangerous side effects of steroid treatment, new research from Queen Mary University of London suggests. The phase 2 clinical trial, funded by Barts Charity, looked at the effects of the diabetes drug metformin on patients currently receiving high...
Share
The results of a recent study show that One Drop’s AI-powered glucose predictions are 91.9% accurate for hypoglycemia and 91.6% accurate for hyperglycemia The digital therapeutics company One Drop today presented new results for continuous glucose monitor-based glucose predictions at The 13th International Conference on Advanced Technologies & Treatments for Diabetes in Madrid, Spain....
Share
For the fifth year in a row, Endocrine News spoke with editors from Endocrine Society journals to get the scoop on the top endocrine discoveries of 2019. Here is part 9 of Eureka! 2019. Associate editor for The Journal of Clinical Endocrinology & Metabolism as well as professor at the University of Colorado Anschutz Medical...
Share
For the fifth year in a row, Endocrine News spoke with editors from Endocrine Society journals to get the scoop on the top endocrine discoveries of 2019. Here is part 5 of Eureka! 2019. Endocrine Reviews Associate Editor Anna Gloyn, DPhil, professor of molecular genetics & metabolism and Wellcome Trust Senior Fellow in Basic Biomedical...
Share
For the fifth year in a row, Endocrine News spoke with editors from Endocrine Society journals to get the scoop on the top endocrine discoveries of 2019. Here is part 4 of Eureka! 2019. Endocrine Reviews Editor-in-Chief Daniel J. Drucker, MD, and senior scientist at the Lunenfeld Tanenbaum Research Institute of the Mt. Sinai Hospital...
